Skip to main content

Table 1 Partners in the safety lead-in phase of the MARSYAS II study

From: Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer—study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II

Sponsor Aposcience AG
CRO FGK Clinical Research GmbH
Service provider for IMP storage and distribution ABF Pharmaceutical Services GmbH
Drug manufacturer Austrian Red Cross, Blood Transfusion Service for Upper Austria
Safety lead-in
 Study center 1 Kepler Universitaetsklinikum Linz
 Study center 2 A.oe. Krankenhaus der Elisabethinen Klagenfurt
 Backup study center 1 Fakultní nemocnice u sv. Anny, Brno
 Backup study center 2 Fakultní nemocnice Královské Vinohrady, Prague
 Backup study center 3 Ústřední vojenská nemocnice - Vojenská fakultní nemocnice, Prague